Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

By | January 6, 2022
Researchers determine the cross-reactivity of the SARS-CoV-2 spike glycoprotein-induced antibodies before and after a third SARS-CoV-2 vaccine dose.